1Rubin CE, Haggitt RC, Burmer GC, et al. DNA aneuploidy in co- Ionic biopsies predicts future development of dysplasia in ulcera- tive colitis[ J]. Gastroenterology, 1992,103 ( 5 ) : 1611-1620.
2Kottachchi D, Yung D, Marshall JK. Adherence to guidelines for surveillance colonoscopy in patients with ulcerative colitis at a Ca- nadian quaternary care hospital [ J ]. Can J Gastroenterol,2009,23 (9) :613-617.
3Velayos FS, Liu L, Lewis JD, et al. Prevalence of colorectal cancer surveillance for ulcerative colitis in an integrated health care de- livery system [ J ]. Gastroenterology, 2010,139 ( 5 ) : 1511-1518.
5van den Broek FJ,Stokkers PC, Reitsma JB, et al. Random biop- sies taken during colonoscopic surveillance of patients with long- standing ulcerative colitis : low yield and absence of clinical con- sequences[J]. Am J Gastroenterol,2014,109(5) :715-722.
6Rutter MD,Saunders BP, Wilkinson KH, et al. Most dysplasia in ulcerative colitis is visible at colonoscopy [ J ]. Gastrointest En- dose ,2004,60 ( 3 ) :334-339.
7Navaneethan U, Kochhar G, Venkatesh PG, et al. Random biop- sies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing eholangitis and ulcerative coli- tis[J]. J Crohns Colitis,2013,7(12) :974-981.
